Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...

EyePoint (EYPT) stock rose 10% after the company reported six-month results from a phase 2 study of its drug Duravyu in the treatment of diabetic macular edema. Read more here.

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Some great apes ...

Arsenal Medical announced the completion of the initial cohort enrollment in the EMBO-02 clinical study of the company’s ...

“Our study suggests that people’s mental health and wellbeing could fluctuate over time of day,” said lead study author Dr. Feifei Bu, principal research fellow in statistics and ...

Research using the University College London (UCL) COVID-19 Social Study found people also widely feel happier in the summertime than they do during the winter months. Using survey data from ...

The Swiss National Supercomputing Center, also known as CSCS, built and deployed a new supercomputer in collaboration with Nvidia and HPE.

The study – which tested Carvykti in patients ... including results on overall survival, a secondary endpoint. That should allow some comparisons to be drawn between Carvykti and Abecma in ...

The trial design for ARASTEP is as follows: The primary study endpoint is radiographic progression-free survival by PSMA PET/CT, assessed by a blinded independent central review. Key secondary ...